申请人:AMERICAN CYANAMID COMPANY
公开号:EP0510333A1
公开(公告)日:1992-10-28
This disclosure describes novel substituted oxotremorine derivatives of formula I having nitrogen, oxygen or sulfur groups and the prodrug forms of these derivatives. The compounds have cholinergic activity. Also disclosed are methods for treating diseases of the central nervous system in mammals employing the compounds, pharmaceutical preparations containing the compounds and the processes for the production of the compounds.
本公开描述了具有氮、氧或硫基团的式 I 的新型取代 oxotremorine 衍生物以及这些衍生物的原药形式。这些化合物具有胆碱能活性。还公开了使用这些化合物治疗哺乳动物中枢神经系统疾病的方法、含有这些化合物的药物制剂以及生产这些化合物的工艺。